175 related articles for article (PubMed ID: 21628887)
1. Development and validation of an LC/MS/MS method for the determination of tenofovir in monkey plasma.
Guo J; Meng F; Li L; Zhong B; Zhao Y
Biol Pharm Bull; 2011; 34(6):877-82. PubMed ID: 21628887
[TBL] [Abstract][Full Text] [Related]
2. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
Delahunty T; Bushman L; Robbins B; Fletcher CV
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1907-14. PubMed ID: 19493710
[TBL] [Abstract][Full Text] [Related]
3. Development of a sensitive and specific liquid chromatography/mass spectrometry method for the determination of tenofovir in human plasma.
Bennetto-Hood C; Long MC; Acosta EP
Rapid Commun Mass Spectrom; 2007; 21(13):2087-94. PubMed ID: 17546653
[TBL] [Abstract][Full Text] [Related]
4. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
[TBL] [Abstract][Full Text] [Related]
5. Validation and implementation of liquid chromatographic-mass spectrometric (LC-MS) methods for the quantification of tenofovir prodrugs.
Hummert P; Parsons TL; Ensign LM; Hoang T; Marzinke MA
J Pharm Biomed Anal; 2018 Apr; 152():248-256. PubMed ID: 29433097
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous determination of pradefovir, PMEA and tenofovir in HBV patient serum using liquid chromatography-tandem mass spectrometry and application to phase 2 clinical trial.
Xiao Q; Wang D; Yang W; Chen L; Ding Y; Yang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():133-140. PubMed ID: 27089519
[TBL] [Abstract][Full Text] [Related]
7. Rapid and specific liquid chromatographic tandem mass spectrometric determination of tenofovir in human plasma and its fragmentation study.
Yadav M; Mishra T; Singhal P; Goswami S; Shrivastav PS
J Chromatogr Sci; 2009 Feb; 47(2):140-8. PubMed ID: 19222922
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Sensitive LC-MS-MS Method for the Determination of Adefovir in Human Serum and Urine: Application to a Clinical Pharmacokinetic Study.
Zhang Y; Shen L; Zhan Y; Xiao QQ; Yang J
J Chromatogr Sci; 2016 Apr; 54(4):507-15. PubMed ID: 26657410
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of tenofovir in Beagle dogs after oral dosing of tenofovir dipivoxil fumarate using HPLC-MS/MS analysis].
Wang BL; Hu JP; Sheng L; Chen H; Li Y
Yao Xue Xue Bao; 2013 Mar; 48(3):390-4. PubMed ID: 23724653
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of a non-nucleoside reverse transcriptase inhibitor efavirenz, a nucleoside reverse transcriptase inhibitor emtricitabine and a nucleotide reverse transcriptase inhibitor tenofovir in plasma by liquid chromatography positive ion electrospray tandem mass spectrometry.
Nirogi R; Bhyrapuneni G; Kandikere V; Mudigonda K; Komarneni P; Aleti R; Mukkanti K
Biomed Chromatogr; 2009 Apr; 23(4):371-81. PubMed ID: 18937306
[TBL] [Abstract][Full Text] [Related]
11. [Determination of adefovir in monkey plasma by liquid chromatography-tandem mass spectrometry].
Zhao LY; Chen XY; Zhang Y; Yang HY; Zhong DF
Yao Xue Xue Bao; 2003 Feb; 38(2):120-3. PubMed ID: 12778747
[TBL] [Abstract][Full Text] [Related]
12. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of adefovir in human plasma and its application to a pharmacokinetic study.
Xiong Z; Zhang Y; Qin F; Qin T; Yang S; Li F
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2111-6. PubMed ID: 20630813
[TBL] [Abstract][Full Text] [Related]
13. A novel LC-MS/MS method for simultaneous quantification of tenofovir and lamivudine in human plasma and its application to a pharmacokinetic study.
Matta MK; Burugula L; Pilli NR; Inamadugu JK; J V L N SR
Biomed Chromatogr; 2012 Oct; 26(10):1202-9. PubMed ID: 22222724
[TBL] [Abstract][Full Text] [Related]
14. Sensitive assay for determining plasma tenofovir concentrations by LC/MS/MS.
Delahunty T; Bushman L; Fletcher CV
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):6-12. PubMed ID: 16269276
[TBL] [Abstract][Full Text] [Related]
15. High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
Valluru RK; B PB; S KS; V PK; Kilaru NB
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():117-26. PubMed ID: 23774246
[TBL] [Abstract][Full Text] [Related]
16. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study.
Bi HC; Zhong GP; Zhou S; Chen X; Huang M
Rapid Commun Mass Spectrom; 2005; 19(20):2911-7. PubMed ID: 16167376
[TBL] [Abstract][Full Text] [Related]
17. An LC-MS/MS method for determination of tenofovir (TFV) in human plasma following tenofovir alafenamide (TAF) administration: Development, validation, cross-validation, and use of formic acid as plasma TFV stabilizer.
Xiao D; Ling KHJ; Tarnowski T; Majeed SR; German P; Kearney BP; Zhao Y; Chen YS; Ma L; Zhang T
Anal Biochem; 2020 Mar; 593():113611. PubMed ID: 32035040
[TBL] [Abstract][Full Text] [Related]
18. A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
D'Avolio A; Sciandra M; Siccardi M; Baietto L; Gonzalez de Requena D; Bonora S; Di Perri G
J Chromatogr Sci; 2008 Jul; 46(6):524-8. PubMed ID: 18647474
[TBL] [Abstract][Full Text] [Related]
19. Determination of abacavir, tenofovir, darunavir, and raltegravir in human plasma and saliva using liquid chromatography coupled with tandem mass spectrometry.
Yamada E; Takagi R; Sudo K; Kato S
J Pharm Biomed Anal; 2015 Oct; 114():390-7. PubMed ID: 26112927
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids.
Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA
J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
